 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 15 of 15 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Huang Y. on PAPER: Valla J. et al., 2010, The ε4 allele of apolipoprotein (Apo) E is the major susceptibility gene for late-onset... 11 Nov 2010.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Zhong N. et al., 2008, Recommendation Only. 28 Jul 2008.
|
 |
 |
 |
 |
 |
Huang Y. on NEWS: ApoE’s Secret Revealed? Protein Promotes Aβ Degradation, The study by Jiang et al. is very interesting and important for better understanding... 17 Jun 2008.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Senechal Y. et al., 2008, Recommendation Only. 1 Oct 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Josephs KA. et al., 2008, Recommendation Only. 1 Oct 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Lu Y. et al., 2007, Recommendation Only. 1 Oct 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Rai KS. et al., 2007, Recommendation Only. 1 Oct 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Bandaru VV. et al., 2009, Recommendation Only. 1 Oct 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Ring S. et al., 2007, Recommendation Only. 30 Jul 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Suzuki S. et al., 2007, Recommendation Only. 30 Jul 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Escobar-Khondiker M. et al., 2007, Recommendation Only. 30 Jul 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Marutle A. et al., 2007, Recommendation Only. 30 Jul 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: van der Vlies AE. et al., 2007, Recommendation Only. 7 Jul 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Wakabayashi M. et al., 2007, Recommendation Only. 7 Jul 2007.
|
 |
 |
 |
 |
 |
Huang Y. on PAPER: Poduslo JF. et al., 2007, Recommendation Only. 7 Jul 2007.
|
 |
 |
 |
 |
 |
 |
1 to 15 of 15 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |